Vaxfab Enterprises Ltd Upgraded to Hold as Technicals and Valuation Improve

Technical Trends Shift to Bullish Momentum

The primary catalyst for the rating upgrade is the marked improvement in the technical outlook for Vaxfab Enterprises. The technical grade has shifted from mildly bullish to bullish, signalling stronger market momentum. Key technical indicators reveal a nuanced but positive picture: the Moving Average Convergence Divergence (MACD) is mildly bearish on a weekly basis but bullish monthly, suggesting that longer-term momentum is gaining strength despite short-term fluctuations.

Further supporting this view, Bollinger Bands are bullish on both weekly and monthly charts, indicating price volatility is trending favourably. Daily moving averages also confirm a bullish stance, reinforcing the positive near-term price action. The Relative Strength Index (RSI) remains neutral with no clear signal, while the Know Sure Thing (KST) indicator is mildly bearish weekly but bullish monthly, echoing the mixed but improving momentum.

Price action has been strong recently, with the stock closing at ₹44.74 on 26 March 2026, up 6.52% from the previous close of ₹42.00. The stock’s 52-week high stands at ₹51.98, with a low of ₹11.00, highlighting significant appreciation over the past year.

Valuation Metrics Indicate Attractive Entry Point

Vaxfab Enterprises’ valuation profile has also improved, contributing to the upgrade. The company boasts a Return on Capital Employed (ROCE) of 61.8%, a robust figure that underscores efficient capital utilisation. Its Enterprise Value to Capital Employed ratio stands at a modest 5.7, signalling an attractive valuation relative to the capital base.

Despite the impressive returns, the stock trades at a discount compared to its peers’ historical averages, offering investors a favourable risk-reward proposition. The Price/Earnings to Growth (PEG) ratio is relatively high at 4.9, reflecting the market’s expectations of sustained profit growth, although this also suggests some premium for growth is priced in.

Long-term sales growth has been exceptional, with net sales increasing at an annualised rate of 141.36%, demonstrating strong top-line momentum. This growth trajectory supports the valuation upgrade, even as recent quarterly profits have been flat.

Financial Trend: Flat Quarterly Performance Amid Strong Long-Term Growth

While the recent quarter (Q3 FY25-26) showed flat financial performance, this has not deterred the upgrade. The company reported a Profit After Tax (PAT) of ₹0.23 crore, a sharp decline of 85.6% compared to the previous four-quarter average. Similarly, Profit Before Depreciation, Interest and Taxes (PBDIT) and Profit Before Tax less Other Income (PBT less OI) were at their lowest levels in recent quarters, at ₹0.40 crore and ₹0.39 crore respectively.

Despite this short-term softness, the company’s low average Debt to Equity ratio of 0.09 times reflects a conservative capital structure, reducing financial risk. Moreover, the long-term growth story remains intact, with net sales growing at an annual rate of 141.36% and profits rising 75% over the past year. This strong underlying trend supports the Hold rating, signalling that the company is well-positioned for recovery and future expansion.

Quality Assessment: Mixed but Improving Fundamentals

Vaxfab Enterprises’ quality metrics present a mixed picture. The company’s micro-cap status and relatively modest Market Capitalisation grade reflect its smaller scale and higher volatility compared to larger peers. The Mojo Score stands at 51.0, an improvement from the previous Sell grade, now classified as Hold. This score reflects a balanced assessment of the company’s fundamentals, technicals, and valuation.

Long-term returns have been exceptional, with the stock delivering 273.14% returns over the past year, vastly outperforming the Sensex’s negative 3.52% return over the same period. Over three years, the stock has returned 206.65%, compared to the Sensex’s 30.85%, underscoring its market-beating performance despite recent quarterly softness.

However, the PEG ratio of 4.9 suggests that investors are paying a premium for growth, which may temper expectations. The company’s flat recent earnings and low profitability in the latest quarter highlight the need for cautious optimism.

Market Performance and Price Action

Vaxfab Enterprises has demonstrated strong market performance relative to benchmarks. Year-to-date returns stand at 18.89%, compared to a negative 11.67% for the Sensex. Over the past month, the stock declined 6.97%, slightly outperforming the Sensex’s 8.51% fall. Weekly returns remain positive at 1.75%, while the stock’s 10-year return data is not available.

The stock’s current price of ₹44.74 is approaching its 52-week high of ₹51.98, indicating renewed investor interest. Daily trading ranges on 26 March 2026 were between ₹42.00 and ₹44.99, reflecting increased volatility and buying activity.

Conclusion: Hold Rating Reflects Balanced Outlook

The upgrade of Vaxfab Enterprises Ltd from Sell to Hold is a reflection of improved technical momentum, attractive valuation metrics, and strong long-term growth prospects, balanced against recent flat quarterly earnings and a cautious quality assessment. The company’s low leverage, market-beating returns over one and three years, and bullish technical indicators provide a solid foundation for investors considering exposure to this micro-cap Trading & Distributors stock.

Investors should monitor upcoming quarterly results closely to assess whether the recent earnings softness is a temporary setback or indicative of a longer-term trend. Meanwhile, the stock’s discount to peer valuations and strong capital efficiency metrics make it a compelling candidate for a Hold rating in the current market environment.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today